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Objective: The objective was to evaluate the effects of atrial synchronous biventric-
ular pacing in postoperative patients with severe cardiomyopathy.
Methods:Atrial synchronous biventricular pacing epicardial leads were placed during
cardiac surgery in patients with an ejection fraction of 30% or less. Patients were ran-
domized to usual care pacing, the mode determined by the surgeon (excluding atrial
synchronous biventricular pacing) with a preference for no pacing or atrial pacing
(atrial inhibited pacing); atrial synchronous right ventricular pacing; or atrial synchro-
nous biventricular pacing. Pacing was continued until cessation of hemodynamic
support. At 12 hours postoperatively, patients were randomly tested in each mode
(atrial inhibited, atrial synchronous right ventricular, and atrial synchronous biventric-
ular pacing), and thermodilution outputs were measured.
Results: Forty subjects were randomized. Groups were similar in age (666 11 years),
gender (85%were male), ejection fraction (23%6 6%), QRS duration (1116 30ms),
and surgical indication. There was no difference in stroke index or cardiac index at 12
hours, duration of inotropic or intra-aortic balloon pump support, intensive care unit,
or hospital length of stay. On comparative crossover testing, stroke volume was sim-
ilar with atrial inhibited pacing and atrial synchronous biventricular pacing (59.3 6
13.4 vs 57 6 12.1, respectively, P 5 not significant); however, atrial synchronous
right ventricular pacing was inferior (56 6 12.9, P , .05 for comparison with atrial
inhibited pacing). When compared with atrial inhibited pacing, atrial synchronous bi-
ventricular pacing showed a positive response in 17% of subjects (increase in stroke
volume $ 5%), whereas 41% had a 5% or greater decrease in stroke volume.
Conclusion: Pacing mode affects stroke volume in patients with severe cardiomyop-
athy. Atrial synchronous biventricular pacing was helpful in a minority, but in 41% it
compromised stroke volume.
L
eft ventricular dysfunction is an independent risk factor for increased mortality
in patients undergoing coronary artery bypass grafting (CABG).1 When
compared with patients with normal ejection fractions, these patients more
frequently require inotropic or intra-aortic balloon pump (IABP) support and have
longer lengths of hospital stay.2,3 Given the widespread use and effectiveness of
percutaneous coronary revascularization, the contemporary patient who undergoes
cardiac surgery is more likely to present later in the course of disease and have severe
cardiomyopathy with associated comorbidities. Conduction system abnormalities
after cardiac surgery are common and may portend a negative prognosis.4,5 Accord-
ingly, most patients who undergo CABG receive temporary atrial and right ventricular
(RV) epicardial pacing leads at the time of surgery. Studies in chronic pacing have
demonstrated worse outcomes with RV pacing compared with native conduction in
patients receiving implantable defibrillators for primary prevention of sudden cardiac
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AAI 5 atrial inhibited
ABiV 5 atrial synchronous biventricular
ARV 5 atrial synchronous right ventricular
AV 5 atrioventricular
CABG 5 coronary artery bypass grafting
IABP 5 intra-aortic balloon pump
RV 5 right ventricular
death,6 presumably because RV pacing induces ventricular
dyssynchrony, resulting in reduced cardiac output. In con-
trast, acute and chronic hemodynamic benefits have been
demonstrated with atrial synchronous biventricular (ABiV)
pacing in patients with severely impaired left ventricular sys-
tolic function and a prolonged QRS duration.7-12 Permanent
ABiV pacing confers additional clinical benefits, including
increased exercise tolerance, quality of life, and left ventric-
ular ejection fraction, and reduced heart failure hospitaliza-
tion.9,12
On the basis of these observations, it has been suggested
that temporary ABiV pacing may further improve the postop-
erative management of the patient with severe cardiomy-
opathy after cardiovascular surgery,13-17 and some authors
recommend routine ABiV pacing for all patients with severe
cardiomyopathy undergoing cardiac surgery.18 However, the
role of ABiV pacing after cardiac surgery has been evaluated
in only small numbers of patients post-CABG, and there are
scant data pertaining to those with left ventricular ejection
fractions less than 30%. The purpose of this study was to de-
termine whether ABiV pacing would improve postoperative
hemodynamics, lessen the requirement for IABP or inotropic
support, decrease length of hospital stay, or decrease mortal-
ity in this specific patient population.
Materials and Methods
Patient Selection
All non-urgent coronary bypass and valvular heart surgeries
performed at William Beaumont Hospital, Royal Oak, Michigan,
between October 20, 2004, and January 23, 2006, were screened
for eligibility. A total of 1204 cardiac surgeries were performed at
William Beaumont Hospital and screened for eligibility during the
enrollment period. Eighty-one surgeries (7%) were performed in
patients with a preoperative ejection fraction of 30% or less.
Twenty-eight patients were excluded from enrollment because of
the presence of one of the following: urgent surgery (18 patients);
enrollment in competing clinical trial (5 patients); presence of per-
manent biventricular pacemaker (2 patients); or inability to provide
informed consent (3 patients). Thirteen patients refused consent.
The remaining 40 subjects comprise the study population.
Study Design
The study protocol was approved and monitored by the William
Beaumont Hospital Human Investigations Committee. Patients916 The Journal of Thoracic and Cardiovascular Surgery c Ocwere screened 1 to 7 days before cardiac surgery and underwent
informed consent at that time. Cardiac surgeries were performed
in accordance with accepted surgical practice. Before weaning
from cardiopulmonary bypass, temporary epicardial pacing wires
were sutured into the right atrium, right ventricle, and left ventricle.
Subjects were then randomized in the operating room to 1 of 3 treat-
ment arms: usual care pacing, atrial synchronous right ventricular
(ARV) pacing, or ABiV. Postoperative hemodynamic and clinical
data were recorded for each study subject as detailed below. The
primary study end point was intensive care unit length of stay.
Secondary end points were hospital length of stay, mortality, and
hemodynamic response to each pacing modality. Because of drop-
out in the 2 active pacing arms, on-treatment analysis was performed
in addition to intention-to-treat analysis.
Pacing Protocol
A DDD temporary external pulse generator (Model 5346, Med-
tronic, Inc, Minneapolis, Minn) was used with bipolar epicardial
pacing wires (Model 6495, Medtronic, Inc) positioned on the right
atrium, mid-right ventricle, and mid-left ventricle (left circumflex
distribution). An adaptor was plugged into the ventricular output
of the temporary pacemaker generator enabling simultaneous
pacing of the right and left ventricles in those patients randomized
to the ABiV pacing modality. Pacing thresholds were tested to con-
firm lead function and capture. Depending on the personal prefer-
ence of the operating surgeon, usual care pacing consisted of no
pacing or atrial pacing (AAI) if atrioventricular (AV) conduction
was intact. For ARV, the mode was DDD, heart rate was
programmed to 85 beats/min or more, and AV delay was 150
ms. ABiV was performed in the DDD mode with a heart rate of
85 beats/min or more and an AV delay programmed to 150 ms
or less to ensure ventricular pacing. Pacing with the assigned mo-
dality was continued until the cessation of vasopressors, inotropes,
or IABP support.
Hemodynamic Data Collection and Analysis
Hemodynamic testing with AAI, ARV, and ABiV pacing was per-
formed in each subject at 12 hours postoperatively (or when clini-
cally feasible) at a time when the doses of vasopressors, inotropes,
or degree of IABP support could be safely maintained at a constant
level for the 40-minute duration of testing. The sequence of pacing
modes during hemodynamic testing was random. The use of new
medications, transfusion of blood products, or change in fluid
administration or ventilator setting during the testing sequence
was avoided if at all possible.
The standard minimum paced heart rate was 85 beats/min. If
the subject’s sinus rate was greater than this rate, the lower rate
limit of the pacer was increased to 10 beats/min above the sinus
rate. The AV interval was adjusted to ensure active ventricular
pacing and kept constant during the ARV and ABiV pacing tests.
After 5 minutes of pacing in each modality, thermodilution car-
diac outputs were measured by injecting 10 mL of normal saline
through a 7F Swan-Ganz catheter (Edwards Life Sciences LLC,
Irvine, Calif) positioned in the pulmonary artery. Five outputs
were measured for each pacing modality. The high and low
values were discarded, with the remaining 3 averaged for report-
ing. Five-minute delays were instituted after each change in
pacing modality before repeating thermodilution cardiac output
measurements.tober 2008
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Clinical, operative, and in-hospital data were recorded in a computer
database. Clinical variables recorded were gender, age, height,
weight, race, medical history, medications, ejection fraction, pulse
repetition interval, QRS duration, and conduction disturbance.
Operative data recorded included surgical date, indication, proce-
dure(s) performed, and duration of cardiopulmonary bypass. In-
hospital variables were intensive care unit length of stay, inpatient
length of stay, mortality, postoperative complications, and duration
of pharmacologic or mechanical hemodynamic support and
mechanical ventilation. Left ventricular ejection fractions were de-
termined by 2 independent readers using one of the following imag-
ing modalities: left-sided heart catheterization with quantitative left
ventriculography (QuantCor LVA, Siemens, Forchheim, Germany);
transthoracic or transesophageal echocardiography (General Elec-
tric Vivid 7, Milwaukee, Wis; Siemens Sequoia; or Hewlett Packard
IE33, Wilmington, Del); multiple gated acquisition scan; quantita-
tive cardiac cine magnetic resonance imaging (Argus, Siemens).
Patients with ejection fractions of 30% or less by the most recent
determination were included in the study.
Statistics
The calculated sample size was 400 patients. A pilot phase of 40
subjects is reported in the present study, which was powered to de-
tect a 15% acute hemodynamic treatment effect with a power of 0.95
at a significance of .05. Statistical analysis was performed using
SAS 9.1 (Cary, NC). Randomization was accomplished by prospec-
tive generation of a 3-number random number table and applying
the group assignment in a blinded fashion sequentially to eachThe Journal of Thorpatient randomized. Data were analyzed on an intention-to-treat
basis. Normal distributed repeated measures were analyzed with
analysis of variance. Non-normal continuous variables were ana-
lyzed with the Kruskal–Wallis nonparametric test. Data are reported
as mean 6 1 standard deviation followed by the median. Categoric
variables were compared with a chi-square test when appropriate;
otherwise, a Fisher exact test was used.
Results
Patient Demographics
The clinical characteristics of the patient population are
summarized in Table 1. The majority of patients enrolled
were male with a mean age 666 11 years. The mean left ven-
tricular ejection fraction was 23%6 6%, and 53% had a his-
tory of congestive heart failure. The 3 treatment groups were
similar in age, gender, preoperative ejection fraction, New
York Heart Association class, QRS duration, preoperative
medications, surgical indication, cardiopulmonary bypass
duration, and surgical procedure(s) performed. The mean
QRS duration was 1116 30 ms. Eleven patients had a signif-
icant intraventricular conduction delay on the preoperative
electrocardiogram: left bundle branch block in 4 patients,
right bundle branch block in 5 patients, and nonspecific intra-
ventricular conduction defect in 2 patients. Of the surgical
procedures performed, 23 were CABG, 9 were combined
CABG and valve repair or replacement, 7 were isolated
valve repairs or replacements, and 1 was left ventricularTABLE 1. Clinical characteristics of study population
Entire cohort Usual care ARV pacing ABiV pacing P value
No. 40 13 14 13
Age (y) 66 6 11 (66.5) 68 6 8 (68) 63 6 13 (64) 66 6 13 (66) .69
Sex (male) 34 (85%) 10 (77%) 14 (100%) 10 (77%) .16
EF 23 6 6 (25) 24 6 7 (25) 23 6 6 (23) 23 6 5 (23) .89
QRS (msec) 111 6 30 (99) 116 6 37 (100) 99 6 13 (99) 119 6 33 (103) .50
LBBB 4 (10%) 2 (15%) 0 2 (15%) .37
RBBB 5 (12.5%) 2 (15%) 0 3 (23%) .17
IVCD 2 (5%) 0 2 (14%) 0 .32
Hypertension 28 (70%) 11 (85%) 9 (64%) 8 (62%) .47
Diabetes mellitus 16 (40%) 5 (38%) 6 (43%) 5 (38%) .96
Hyperlipidemia 26 (65%) 6 (46%) 11 (79%) 9 (69%) .25
PVD 6 (15%) 2 (15%) 2 (14%) 2 (15%) 1.00
CHF 21 (53%) 8 (62%) 5 (36%) 8 (62%) .30
Previous MI 24 (60%) 9 (69%) 7 (50%) 8 (62%) .59
COPD 7 (18%) 2 (15%) 2 (14%) 3 (23%) .88
CABG 32 (80%) 8 (62%) 14 (100%) 10 (77%) .03
Mitral regurgitation 16 (40%) 3 (23%) 8 (57%) 5 (38%) .19
Aortic insufficiency 9 (23%) 2 (15%) 2 (14%) 3 (23%) .88
Aortic stenosis 10 (25%) 4 (31%) 3 (21%) 3 (23%) .90
Valve surgery 16 (40%) 5 (38%) 7 (50%) 4 (31%) 0.59
ARV, Atrial synchronous right ventricular; ABiV, atrial synchronous biventricular; CABG, coronary artery bypass graft surgery; CHF, congestive heart failure;
COPD, chronic obstructive coronary disease; EF, ejection fraction; IVCD, intraventricular conduction defect; LBBB, left bundle branch block;MI, myocardial
infarction; PVD, peripheral vascular disease; RBBB, right bundle branch block. Data are expressed as means6 standard deviation (median value or percent-
age).acic and Cardiovascular Surgery c Volume 136, Number 4 917
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pulmonary bypass.
Hemodynamic Testing
Twenty-nine of the 40 subjects (73%) completed hemody-
namic testing in all 3 pacing modalities approximately 12
hours after surgery. Testing was not completed because of
complete heart block in 3 subjects, lead capture failures in
3 subjects, atrial fibrillation in 2 subjects, painful pacing stim-
uli in 2 subjects, and inadvertent removal of the pulmonary
artery catheter before testing in 1 subject. The results of
this testing are shown in Table 2. For this study population,
ABiV pacing mode yielded hemodynamic results similar to
the AAI pacing mode, including stroke volume (57.0 vs
59.3 mL, P 5 not significant), cardiac output (5.4 vs 5.5 L/
min, P5 not significant), and left ventricular stroke work in-
dex (23.8 vs 24.5 gm-m/beat, P5 not significant). Five of 29
patients (17%) had more than 5% improvement in stroke vol-
ume, cardiac output, or left ventricular stroke work index
with ABiV compared with AAI pacing; however, 12 of 29
patients (41%) experienced a greater than 5% decrease in he-
modynamics (Figure 1). An association between hemody-
namic benefit from the biventricular pacing mode and
baseline QRS duration, New York Heart Association class,
severity of mitral regurgitation, or surgical indication was
not observed. A trend toward lower baseline left ventricular
ejection fraction was seen in subjects with a positive response
to the ABiV pacing mode (20% 6 8%) versus those with
a negative response (23% 6 6%), but this did not achieve
statistical significance.
When ARV pacing mode was compared with AAI pacing
mode, a decrease in hemodynamic function was observed
with single-site RV pacing. Stroke volume (56.0 vs 59.3
mL, P , .05), cardiac output (5.3 vs 5.5 L/min, P , .05),
and left ventricular stroke work index (22.9 vs 24.5 gm-m/
beat, P , .05) were all reduced. Furthermore, 48% of sub-918 The Journal of Thoracic and Cardiovascular Surgery c Octjects demonstrated an adverse hemodynamic response to
ARV pacing compared with AAI pacing, compared with
17% of patients who improved in the ARV mode (Figure 1).
There was no association between response to ARV pacing
and baseline left ventricular ejection fraction, QRS duration,
New York Heart Association class, severity of mitral regurgi-
tation, or surgical indication. No significant differences in
acute hemodynamics could be discerned between ARV and
ABiV pacing modes.
Outcomes of Pacing
Thirty of 40 patients maintained the assigned pacing
modality until completion of the pacing period (cessation
of vasopressors, inotropes, or IABP support). Ten subjects
had early crossover or discontinuation of pacing because of
failure of capture in the atrial or ventricular lead (n 5 5),
onset of atrial fibrillation with rapid ventricular response
(n 5 2), hypotension with ventricular pacing (n 5 2), and
painful muscle stimulation (n 5 1). One patient assigned to
the ARV pacing group died of cardiogenic shock compli-
cated by ventilator-associated pneumonia and sepsis on hos-
pital day 25. Of the 13 subjects randomized to the usual care
pacing arm, 6 received no pacing, 4 received atrial pacing,
and 3 received AV sequential pacing because of postopera-
tive heart block. Outcomes by group assignment are listed
in Table 3. Because of the high crossover rate, both inten-
tion-to-treat and on-treatment analyses were performed.
Among the 3 pacing modes, there were no statistically signif-
icant differences in the predetermined primary or secondary
end points of intensive care unit length of stay, hospital
length of stay, mortality, or hemodynamic parameters
measured 12 hours postoperatively for either analysis.
Discussion
Anecdotal observations have led some to consider routine
biventricular pacing for patients with severe cardiomyopathyTABLE 2. Acute hemodynamic outcomes during crossover testing
Usual care ARV pacing ABiV pacing P value
Heart rate (bpm) 94 6 10 (91) 94 6 8 (91) 95 6 8 (94) .90
Mean blood pressure (mm Hg) 75 6 11 (74) 78 6 15 (75) 78 6 12 (78) .52
Mean PAP (mm Hg) 25 6 5 (25) 25 6 5 (25) 25 6 5 (24) .99
PCWP (mm Hg) 18 6 5 (18) 18 6 5 (17) 18 6 5 (18).3 (22.6) .87
Stroke volume (mL) 56.0 6 13.7 (54.9)* 57.0/-12.4 (55.4) 59.3 6 11.9 (58.1) .92
Cardiac output (L/min) 5.3 6 1.1 (5.3)* 5.4 6 0.9 (5.2) 5.5 6 1.0 (5.4) .97
Cardiac index (L/min/m2) 2.7 6 0.6 (2.6) 2.7 6 0.4 (2.6) 2.8 6 0.4 (2.7) .83
SVRI 2176 6 1350 2277 6 1432 1971 6 391 .56
Stroke index 29.6 6 6.0 (28.2) 29.0 6 5.5 (27.9) 29.2 6 5.5 (27.9) .97
LVSWI (gm-m/beat) 22.9 6 7.2 (21.2)* 23.8 6 7.7 (22.8) 24.5 6 7.3 .57
ARV, Atrial synchronous right ventricular; ABiV, atrial synchronous biventricular; LVSWI, left ventricular stroke work index; PAP, pulmonary artery pressure;
PCWP, pulmonary capillary wedge pressure; SVRI, systemic vascular resistance index. *P, .05 ARV versus AAI pacing mode. Data are expressed as means
6 standard deviation (median value).ober 2008
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port using ABiV pacing ‘‘without difficulty in all high risk
cases for the past two years’’ and recommends widespread
use in ‘‘all high-risk cardiac surgery patients.’’ To test this
hypothesis, the present pilot study sought to compare 3 tem-
porary pacing modes in a cohort of patients with significant
left ventricular dysfunction who underwent cardiac surgery.
The results failed to demonstrate consistent superiority of
ABiV when broadly applied to the postoperative manage-
ment of these patients. In fact, ABiV resulted in diverse
hemodynamic responses among individuals in this study
population, with 17% of patients demonstrating improved
hemodynamics and 41% showing worsened measurements.
With hemodynamic testing performed in each pacing modal-
ity in the early postoperative period, we were unable to
demonstrate statistically significant differences in any hemo-
dynamic parameters among the 3 groups. However, ARV
resulted in worse hemodynamics overall, with a decline in
function in more than one half of the population studied in
this mode. The overall outcomes were similar for all 3 groups
in pacing mode assignment and pacing mode received. No
conclusions could be drawn about the clinical outcomes of
this study because it was not adequately powered to do so.
Previous Studies
The observations from the present pilot trial are not consis-
tent with those reported in several small nonrandomized sur-
gical studies that suggested biventricular pacing favorably
affects postoperative hemodynamics in patient undergoing
cardiac surgery.13-15 The disparate findings among studies
Figure 1. Stroke volume versus pacing
mode during crossover hemodynamic
testing. A, AAI pacing compared with
ABiV pacing. B, AAI pacing compared
with ARV pacing. Each symbol repre-
sents an individual study subject's
stroke volume in each pacing mode.
Subjects who had no significant change
(<5%) (triangleswith dotted lines), sub-
jects who had a decrease of 5% or more
(diamonds with solid black lines), and
subjects who had a 5% or greater im-
provement in hemodynamic parameters
with crossover to the alternate pacing
mode (squares with grey lines) are
shown. Mean 6 standard error of the
mean (large squares).
TABLE 3. Clinical outcome based on intention-to-treat analysis of study group assignment
Entire cohort Usual care ARV pacing ABiV pacing P value
No. 40 13 14 13
ICU LOS (h) 87 6 92 (63) 71 6 47 (70) 101 6 141 (45) 89 6 58 (66) .62
Heart rate 94 6 9 (94) 93 6 7 (96) 95 6 13 (92) 95 6 7 (94) .46
Stroke index 29 6 5 (28) 29.3 6 4.8 (29.4) 28.7 6 5.8 (28) 29 6 5.6 (27.7) .84
Cardiac index 2.72 6 0.5 (2.67) 2.70 6 0.3 (2.7) 2.73 6 0.7 (2.55) 2.74 6 0.5 (2.75) .77
Duration of inotropic support (h) 39 6 61 (16) 43 6 84 (9) 48 6 64 (17) 25 6 21 (17) .35
IABP 11 (28%) 3 (23%) 3 (21%) 5 (38%) .67
Duration IABP (h) 46 6 50 (27) 39 6 18 (46) 88 6 92 (49) 25 6 6 (23) .30
Duration ventilation (h) 37 6 88 (15) 21 6 22 (12) 60 6 147 (15) 27 6 23 (24) .38
Hospital LOS (d) 14.4 6 7.5 (13) 16 6 9 (17) 15 6 7 (16) 12 6 7 (11) .22
Postoperative AF 15 (38%) 7 (54%) 6 (43%) 4 (31%) .49
Mortality 1 (2.5%) 0 1 (7%) 0
ABiV, Atrial synchronous biventricular; ARV, atrial synchronous right ventricular; AF, atrial fibrillation; IAPB, intra-aortic balloon pump; ICU, intensive care unit;
LOS, length of stay. Data are expressed as means 6 standard deviation (median value or percentage).The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 4 919
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cols, and methodologies for hemodynamic and clinical data
acquisition. Foster and colleagues13 demonstrated a 7.6%
increase in cardiac index with biventricular pacing when
compared with AAI pacing. There were only 18 subjects in
the study, and most had preserved left ventricular systolic
function. Subjects were excluded if the cardiac index was
less than 2.0 L/min/m2 or if IABP support was required.
Weisse and colleagues14 compared pacing modalities in 22
patients with a left ventricular ejection fraction less than
40% and new bundle branch block after cardiac surgery.
Among the 12 patients with left bundle branch block, biven-
tricular pacing improved the cardiac index by 14.5% when
compared with AAI pacing. In the 10 patients with right bun-
dle branch block, ABiV pacing improved cardiac index by
14.1% versus AAI pacing. The present cohort represented
a more ill population of patients than previously tested. The
mean left ventricular ejection fraction was 23%, 53% had
a history of heart failure, and 28% required IABP support.
Successful resynchronization is dependent on optimal
placement of the pacing electrodes.19 If the site selected for
left ventricular pacing is diseased, particularly with transmu-
ral infarct scar, the electrical conduction emanating from that
site may be slow, and the left ventricular activation, in turn,
may be delayed.20,21 The present pacing protocol required
epicardial leads to be positioned in the mid-right ventricle
and mid-left ventricle along the distribution of the left
circumflex coronary artery. This widely spaced electrode
configuration has been demonstrated in previous work to
result in a greater likelihood of synchronous ventricular con-
traction.22 In contrast, the previous studies used paraseptal
left ventricular and RV lead placement.14,15 It might be
anticipated that placement of paraseptal left ventricular and
RV leads close to one another would not result in true syn-
chronous pacing in all individuals. The study by Saxon and
colleagues15 compared asynchronous ventricular pacing
modes with sinus rhythm and did so intraoperatively in an
open chest. This less-physiologic methodology makes it
difficult to draw strong conclusions from these observations.
Limitations
The present study was a pilot study by design and therefore
did not have a large enough population to achieve adequate
statistical power to detect small differences in clinical out-
comes among the 3 groups. In addition, the high crossover
rate during pacing makes it difficult to draw conclusions
about the clinical end points based on the intention-to-treat
analysis. Nonetheless, this work represents the largest
randomized trial to date comparing postoperative hemody-
namics with different pacing modalities in this patient popu-
lation. Our patients were intentionally not selected on the
basis of electrocardiographic or echocardiographic parame-
ters of dyssynchrony. We chose to include all patients with
an EF of 30% or less to make this study more widely920 The Journal of Thoracic and Cardiovascular Surgery c Octapplicable. As a result, only a minority of subjects in this pop-
ulation had preexisting bundle branch block. Our findings
may have been different had the participants had evidence
of dyssynchrony. The final AV interval was not recorded
prospectively, and the AV and VV timing intervals were
not optimized. Differences in AV intervals among groups
may have affected acute hemodynamics and late outcomes,
and AV and VV timing optimization could have improved
response to BiV pacing.23,24 The hours postsurgery are a dy-
namic period; testing was performed by protocol 12 hours
postoperatively, but biventricular pacing might have shown
different acute hemodynamic results had the randomized
testing been performed at a different time interval.
Conclusions
Patients with significant left ventricular dysfunction undergo-
ing cardiac surgery did not show substantive benefit with
ABiV compared with atrial pacing alone, but atrial synchro-
nous RV pacing led to an acute decrease in hemodynamics.
Individual hemodynamic responses to biventricular pacing
were highly variable. Although biventricular pacing might
result in hemodynamic advantage in some patients, routine
biventricular pacing in all high-risk patients undergoing
cardiac surgery could result in more harm than benefit. There-
fore, normal sinus rhythm or atrial pacing alone is preferable
to any ventricular pacing if the heart rate can be maintained
adequately. If heart block results in a need for ventricular
pacing, then ABiV may be preferable to RV pacing. Further
larger trials will need to be performed to elucidate these
questions.
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